English
简体中文
Total: £ 56.28
Published Date: 2026-03-25 | Pages: 120 | Tables: 111 | Pharma & Healthcare
The global Drugs Produced by Fermentation Engineering market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Fermentation is a process used for cultivating micro-organisms or other organic material into important drugs such as antibiotics, therapeutic proteins, enzymes and insulin. It is typically carried out in temperature-controlled tanks (fermenter) which require addition of nutrients at the correct concentration to maximize productivity of the organism of interest.
In China, 5 largest manufacturers of Fermentation Engineering for Pharmaceutical Drugs are Changchun GeneScience Pharmaceutical, 3SBio Inc, Shanghai Fosun Pharmaceutical, Sichuan Kelun Pharmaceutical and Shanghai Shyndec Pharmaceutical, which make up over 15%. Among them, Changchun GeneScience Pharmaceutical is the leader with about 6% market share. In terms of product type, Monoclonal Antibodies occupy the largest share of the total market, about 54%. And in terms of product Application, the largest application is Hospital, followed by Clinic.
This report delivers a comprehensive overview of the global Drugs Produced by Fermentation Engineering market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drugs Produced by Fermentation Engineering. The Drugs Produced by Fermentation Engineering market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drugs Produced by Fermentation Engineering market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drugs Produced by Fermentation Engineering manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group
Segment by Type
Monoclonal Antibodies
Antibiotic
Insulin
Human Growth Hormone
Pharmaceutical Amino Acids
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drugs Produced by Fermentation Engineering companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Monoclonal Antibodies
1.2.3 Antibiotic
1.2.4 Insulin
1.2.5 Human Growth Hormone
1.2.6 Pharmaceutical Amino Acids
1.2.7 Others
1.3 Market by Application
1.3.1 Global Drugs Produced by Fermentation Engineering Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs Produced by Fermentation Engineering Market Perspective (2021–2032)
2.2 Global Drugs Produced by Fermentation Engineering Growth Trends by Region
2.2.1 Global Drugs Produced by Fermentation Engineering Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Drugs Produced by Fermentation Engineering Historic Market Size by Region (2021–2026)
2.2.3 Drugs Produced by Fermentation Engineering Forecasted Market Size by Region (2027–2032)
2.3 Drugs Produced by Fermentation Engineering Market Dynamics
2.3.1 Drugs Produced by Fermentation Engineering Industry Trends
2.3.2 Drugs Produced by Fermentation Engineering Market Drivers
2.3.3 Drugs Produced by Fermentation Engineering Market Challenges
2.3.4 Drugs Produced by Fermentation Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs Produced by Fermentation Engineering Players by Revenue
3.1.1 Global Top Drugs Produced by Fermentation Engineering Players by Revenue (2021–2026)
3.1.2 Global Drugs Produced by Fermentation Engineering Revenue Market Share by Players (2021–2026)
3.2 Global Top Drugs Produced by Fermentation Engineering Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Drugs Produced by Fermentation Engineering Revenue
3.4 Global Drugs Produced by Fermentation Engineering Market Concentration Ratio
3.4.1 Global Drugs Produced by Fermentation Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs Produced by Fermentation Engineering Revenue in 2025
3.5 Global Key Players of Drugs Produced by Fermentation Engineering Head Offices and Areas Served
3.6 Global Key Players of Drugs Produced by Fermentation Engineering, Products and Applications
3.7 Global Key Players of Drugs Produced by Fermentation Engineering, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Drugs Produced by Fermentation Engineering Breakdown Data by Type
4.1 Global Drugs Produced by Fermentation Engineering Historic Market Size by Type (2021–2026)
4.2 Global Drugs Produced by Fermentation Engineering Forecasted Market Size by Type (2027–2032)
5 Drugs Produced by Fermentation Engineering Breakdown Data by Application
5.1 Global Drugs Produced by Fermentation Engineering Historic Market Size by Application (2021–2026)
5.2 Global Drugs Produced by Fermentation Engineering Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Drugs Produced by Fermentation Engineering Market Size (2021–2032)
6.2 North America Drugs Produced by Fermentation Engineering Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Drugs Produced by Fermentation Engineering Market Size by Country (2021–2026)
6.4 North America Drugs Produced by Fermentation Engineering Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs Produced by Fermentation Engineering Market Size (2021–2032)
7.2 Europe Drugs Produced by Fermentation Engineering Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Drugs Produced by Fermentation Engineering Market Size by Country (2021–2026)
7.4 Europe Drugs Produced by Fermentation Engineering Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Drugs Produced by Fermentation Engineering Market Size (2021–2032)
8.2 Asia-Pacific Drugs Produced by Fermentation Engineering Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Drugs Produced by Fermentation Engineering Market Size by Region (2021–2026)
8.4 Asia-Pacific Drugs Produced by Fermentation Engineering Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Drugs Produced by Fermentation Engineering Market Size (2021–2032)
9.2 Latin America Drugs Produced by Fermentation Engineering Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Drugs Produced by Fermentation Engineering Market Size by Country (2021–2026)
9.4 Latin America Drugs Produced by Fermentation Engineering Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size (2021–2032)
10.2 Middle East & Africa Drugs Produced by Fermentation Engineering Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (2021–2026)
10.4 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Changchun GeneScience Pharmaceutical
11.1.1 Changchun GeneScience Pharmaceutical Company Details
11.1.2 Changchun GeneScience Pharmaceutical Business Overview
11.1.3 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.1.4 Changchun GeneScience Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.1.5 Changchun GeneScience Pharmaceutical Recent Development
11.2 3SBio Inc
11.2.1 3SBio Inc Company Details
11.2.2 3SBio Inc Business Overview
11.2.3 3SBio Inc Drugs Produced by Fermentation Engineering Introduction
11.2.4 3SBio Inc Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.2.5 3SBio Inc Recent Development
11.3 Shanghai Fosun Pharmaceutical
11.3.1 Shanghai Fosun Pharmaceutical Company Details
11.3.2 Shanghai Fosun Pharmaceutical Business Overview
11.3.3 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.3.4 Shanghai Fosun Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.3.5 Shanghai Fosun Pharmaceutical Recent Development
11.4 Sichuan Kelun Pharmaceutical
11.4.1 Sichuan Kelun Pharmaceutical Company Details
11.4.2 Sichuan Kelun Pharmaceutical Business Overview
11.4.3 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.4.4 Sichuan Kelun Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.4.5 Sichuan Kelun Pharmaceutical Recent Development
11.5 Shanghai Shyndec Pharmaceutical
11.5.1 Shanghai Shyndec Pharmaceutical Company Details
11.5.2 Shanghai Shyndec Pharmaceutical Business Overview
11.5.3 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.5.4 Shanghai Shyndec Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.5.5 Shanghai Shyndec Pharmaceutical Recent Development
11.6 CSPC Pharmaceutical Group
11.6.1 CSPC Pharmaceutical Group Company Details
11.6.2 CSPC Pharmaceutical Group Business Overview
11.6.3 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Introduction
11.6.4 CSPC Pharmaceutical Group Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.6.5 CSPC Pharmaceutical Group Recent Development
11.7 United Laboratories International Holdings
11.7.1 United Laboratories International Holdings Company Details
11.7.2 United Laboratories International Holdings Business Overview
11.7.3 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Introduction
11.7.4 United Laboratories International Holdings Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.7.5 United Laboratories International Holdings Recent Development
11.8 Tonghua Dongbao Pharmaceutical
11.8.1 Tonghua Dongbao Pharmaceutical Company Details
11.8.2 Tonghua Dongbao Pharmaceutical Business Overview
11.8.3 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Introduction
11.8.4 Tonghua Dongbao Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.8.5 Tonghua Dongbao Pharmaceutical Recent Development
11.9 Joincare Pharmaceutical Group
11.9.1 Joincare Pharmaceutical Group Company Details
11.9.2 Joincare Pharmaceutical Group Business Overview
11.9.3 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Introduction
11.9.4 Joincare Pharmaceutical Group Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.9.5 Joincare Pharmaceutical Group Recent Development
11.10 North China Pharma
11.10.1 North China Pharma Company Details
11.10.2 North China Pharma Business Overview
11.10.3 North China Pharma Drugs Produced by Fermentation Engineering Introduction
11.10.4 North China Pharma Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.10.5 North China Pharma Recent Development
11.11 Anhui Anke Biotechnology
11.11.1 Anhui Anke Biotechnology Company Details
11.11.2 Anhui Anke Biotechnology Business Overview
11.11.3 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Introduction
11.11.4 Anhui Anke Biotechnology Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.11.5 Anhui Anke Biotechnology Recent Development
11.12 Gan and Lee Pharmaceuticals
11.12.1 Gan and Lee Pharmaceuticals Company Details
11.12.2 Gan and Lee Pharmaceuticals Business Overview
11.12.3 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Introduction
11.12.4 Gan and Lee Pharmaceuticals Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.12.5 Gan and Lee Pharmaceuticals Recent Development
11.13 Shandong Kexing Bioproducts
11.13.1 Shandong Kexing Bioproducts Company Details
11.13.2 Shandong Kexing Bioproducts Business Overview
11.13.3 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Introduction
11.13.4 Shandong Kexing Bioproducts Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.13.5 Shandong Kexing Bioproducts Recent Development
11.14 Harbin Pharmaceutical Group
11.14.1 Harbin Pharmaceutical Group Company Details
11.14.2 Harbin Pharmaceutical Group Business Overview
11.14.3 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Introduction
11.14.4 Harbin Pharmaceutical Group Revenue in Drugs Produced by Fermentation Engineering Business (2021–2026)
11.14.5 Harbin Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Antibiotic
Table 4. Key Players of Insulin
Table 5. Key Players of Human Growth Hormone
Table 6. Key Players of Pharmaceutical Amino Acids
Table 7. Key Players of Others
Table 8. Global Drugs Produced by Fermentation Engineering Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Drugs Produced by Fermentation Engineering Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global Drugs Produced by Fermentation Engineering Market Size by Region (US$ Million), 2021–2026
Table 11. Global Drugs Produced by Fermentation Engineering Market Share by Region (2021–2026)
Table 12. Global Drugs Produced by Fermentation Engineering Forecasted Market Size by Region (US$ Million), 2027–2032
Table 13. Global Drugs Produced by Fermentation Engineering Market Share by Region (2027–2032)
Table 14. Drugs Produced by Fermentation Engineering Market Trends
Table 15. Drugs Produced by Fermentation Engineering Market Drivers
Table 16. Drugs Produced by Fermentation Engineering Market Challenges
Table 17. Drugs Produced by Fermentation Engineering Market Restraints
Table 18. Global Drugs Produced by Fermentation Engineering Revenue by Players (US$ Million), 2021–2026
Table 19. Global Drugs Produced by Fermentation Engineering Market Share by Players (2021–2026)
Table 20. Global Top Drugs Produced by Fermentation Engineering Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drugs Produced by Fermentation Engineering Revenue, 2025
Table 21. Ranking of Global Top Drugs Produced by Fermentation Engineering Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Drugs Produced by Fermentation Engineering Revenue (CR5 and HHI), 2021–2026
Table 23. Global Key Players of Drugs Produced by Fermentation Engineering, Headquarters and Area Served
Table 24. Global Key Players of Drugs Produced by Fermentation Engineering, Products and Applications
Table 25. Global Key Players of Drugs Produced by Fermentation Engineering, Date of General Availability (GA)
Table 26. Mergers and Acquisitions, Expansion Plans
Table 27. Global Drugs Produced by Fermentation Engineering Market Size by Type (US$ Million), 2021–2026
Table 28. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Type (2021–2026)
Table 29. Global Drugs Produced by Fermentation Engineering Forecasted Market Size by Type (US$ Million), 2027–2032
Table 30. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Type (2027–2032)
Table 31. Global Drugs Produced by Fermentation Engineering Market Size by Application (US$ Million), 2021–2026
Table 32. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2021–2026)
Table 33. Global Drugs Produced by Fermentation Engineering Forecasted Market Size by Application (US$ Million), 2027–2032
Table 34. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2027–2032)
Table 35. North America Drugs Produced by Fermentation Engineering Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. North America Drugs Produced by Fermentation Engineering Market Size by Country (US$ Million), 2021–2026
Table 37. North America Drugs Produced by Fermentation Engineering Market Size by Country (US$ Million), 2027–2032
Table 38. Europe Drugs Produced by Fermentation Engineering Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. Europe Drugs Produced by Fermentation Engineering Market Size by Country (US$ Million), 2021–2026
Table 40. Europe Drugs Produced by Fermentation Engineering Market Size by Country (US$ Million), 2027–2032
Table 41. Asia-Pacific Drugs Produced by Fermentation Engineering Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 42. Asia-Pacific Drugs Produced by Fermentation Engineering Market Size by Region (US$ Million), 2021–2026
Table 43. Asia-Pacific Drugs Produced by Fermentation Engineering Market Size by Region (US$ Million), 2027–2032
Table 44. Latin America Drugs Produced by Fermentation Engineering Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Latin America Drugs Produced by Fermentation Engineering Market Size by Country (US$ Million), 2021–2026
Table 46. Latin America Drugs Produced by Fermentation Engineering Market Size by Country (US$ Million), 2027–2032
Table 47. Middle East & Africa Drugs Produced by Fermentation Engineering Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (US$ Million), 2021–2026
Table 49. Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (US$ Million), 2027–2032
Table 50. Changchun GeneScience Pharmaceutical Company Details
Table 51. Changchun GeneScience Pharmaceutical Business Overview
Table 52. Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Product
Table 53. Changchun GeneScience Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 54. Changchun GeneScience Pharmaceutical Recent Development
Table 55. 3SBio Inc Company Details
Table 56. 3SBio Inc Business Overview
Table 57. 3SBio Inc Drugs Produced by Fermentation Engineering Product
Table 58. 3SBio Inc Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 59. 3SBio Inc Recent Development
Table 60. Shanghai Fosun Pharmaceutical Company Details
Table 61. Shanghai Fosun Pharmaceutical Business Overview
Table 62. Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Product
Table 63. Shanghai Fosun Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 64. Shanghai Fosun Pharmaceutical Recent Development
Table 65. Sichuan Kelun Pharmaceutical Company Details
Table 66. Sichuan Kelun Pharmaceutical Business Overview
Table 67. Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Product
Table 68. Sichuan Kelun Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 69. Sichuan Kelun Pharmaceutical Recent Development
Table 70. Shanghai Shyndec Pharmaceutical Company Details
Table 71. Shanghai Shyndec Pharmaceutical Business Overview
Table 72. Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Product
Table 73. Shanghai Shyndec Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 74. Shanghai Shyndec Pharmaceutical Recent Development
Table 75. CSPC Pharmaceutical Group Company Details
Table 76. CSPC Pharmaceutical Group Business Overview
Table 77. CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Product
Table 78. CSPC Pharmaceutical Group Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 79. CSPC Pharmaceutical Group Recent Development
Table 80. United Laboratories International Holdings Company Details
Table 81. United Laboratories International Holdings Business Overview
Table 82. United Laboratories International Holdings Drugs Produced by Fermentation Engineering Product
Table 83. United Laboratories International Holdings Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 84. United Laboratories International Holdings Recent Development
Table 85. Tonghua Dongbao Pharmaceutical Company Details
Table 86. Tonghua Dongbao Pharmaceutical Business Overview
Table 87. Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Product
Table 88. Tonghua Dongbao Pharmaceutical Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 89. Tonghua Dongbao Pharmaceutical Recent Development
Table 90. Joincare Pharmaceutical Group Company Details
Table 91. Joincare Pharmaceutical Group Business Overview
Table 92. Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Product
Table 93. Joincare Pharmaceutical Group Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 94. Joincare Pharmaceutical Group Recent Development
Table 95. North China Pharma Company Details
Table 96. North China Pharma Business Overview
Table 97. North China Pharma Drugs Produced by Fermentation Engineering Product
Table 98. North China Pharma Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 99. North China Pharma Recent Development
Table 100. Anhui Anke Biotechnology Company Details
Table 101. Anhui Anke Biotechnology Business Overview
Table 102. Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Product
Table 103. Anhui Anke Biotechnology Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 104. Anhui Anke Biotechnology Recent Development
Table 105. Gan and Lee Pharmaceuticals Company Details
Table 106. Gan and Lee Pharmaceuticals Business Overview
Table 107. Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Product
Table 108. Gan and Lee Pharmaceuticals Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 109. Gan and Lee Pharmaceuticals Recent Development
Table 110. Shandong Kexing Bioproducts Company Details
Table 111. Shandong Kexing Bioproducts Business Overview
Table 112. Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Product
Table 113. Shandong Kexing Bioproducts Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 114. Shandong Kexing Bioproducts Recent Development
Table 115. Harbin Pharmaceutical Group Company Details
Table 116. Harbin Pharmaceutical Group Business Overview
Table 117. Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Product
Table 118. Harbin Pharmaceutical Group Revenue in Drugs Produced by Fermentation Engineering Business (US$ Million), 2021–2026
Table 119. Harbin Pharmaceutical Group Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Authors List of This Report
List of Figures
Figure 1. Drugs Produced by Fermentation Engineering Picture
Figure 2. Global Drugs Produced by Fermentation Engineering Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Drugs Produced by Fermentation Engineering Market Share by Type: 2025 vs 2032
Figure 4. Monoclonal Antibodies Features
Figure 5. Antibiotic Features
Figure 6. Insulin Features
Figure 7. Human Growth Hormone Features
Figure 8. Pharmaceutical Amino Acids Features
Figure 9. Others Features
Figure 10. Global Drugs Produced by Fermentation Engineering Market Size by Application (US$ Million), 2021–2032
Figure 11. Global Drugs Produced by Fermentation Engineering Market Share by Application: 2025 vs 2032
Figure 12. Hospital Case Studies
Figure 13. Clinic Case Studies
Figure 14. Other Case Studies
Figure 15. Drugs Produced by Fermentation Engineering Report Years Considered
Figure 16. Global Drugs Produced by Fermentation Engineering Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global Drugs Produced by Fermentation Engineering Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Drugs Produced by Fermentation Engineering Market Share by Region: 2025 vs 2032
Figure 19. Global Drugs Produced by Fermentation Engineering Market Share by Players in 2025
Figure 20. Global Drugs Produced by Fermentation Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Drugs Produced by Fermentation Engineering Revenue in 2025
Figure 22. North America Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America Drugs Produced by Fermentation Engineering Market Share by Country (2021–2032)
Figure 24. United States Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Drugs Produced by Fermentation Engineering Market Share by Country (2021–2032)
Figure 28. Germany Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Drugs Produced by Fermentation Engineering Market Share by Region (2021–2032)
Figure 36. China Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Drugs Produced by Fermentation Engineering Market Share by Country (2021–2032)
Figure 44. Mexico Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Drugs Produced by Fermentation Engineering Market Share by Country (2021–2032)
Figure 48. Israel Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE Drugs Produced by Fermentation Engineering Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Changchun GeneScience Pharmaceutical Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 52. 3SBio Inc Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 53. Shanghai Fosun Pharmaceutical Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 54. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 55. Shanghai Shyndec Pharmaceutical Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 56. CSPC Pharmaceutical Group Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 57. United Laboratories International Holdings Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 58. Tonghua Dongbao Pharmaceutical Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 59. Joincare Pharmaceutical Group Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 60. North China Pharma Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 61. Anhui Anke Biotechnology Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 62. Gan and Lee Pharmaceuticals Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 63. Shandong Kexing Bioproducts Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 64. Harbin Pharmaceutical Group Revenue Growth Rate in Drugs Produced by Fermentation Engineering Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
